FDA Orange Book · active-ingredient family
Silver sulfadiazine
Silver sulfadiazine is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:SSD · NDA 018578
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · cream, dressing
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SSDRLD×2 | DR REDDYS | NDA 018578 | AB | Feb 25, 1982 | |
| SILVADENERLD | KING PHARMS LLC | NDA 017381 | AB | Approved Prior to Jan 1, 1982 | |
| SILDAFLO | FRANKLIN PHARMS | NDA 019608 | — | Nov 30, 1989 | |
| THERMAZENE | THEPHARMANETWORK LLC | NDA 018810 | AB | Dec 23, 1985 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Silver sulfadiazine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

